Encision Top Management

ECIADelisted Stock  USD 0.44  0.00  0.00%   
Encision employs about 31 people. The company is managed by 7 executives with a total tenure of roughly 110 years, averaging almost 15.0 years of service per executive, having 4.43 employees per reported executive. Analysis of Encision's management performance can provide insight into the company performance.
Gregory Trudel  CEO
CEO and President and Director
Peter Geary  President
Vice President - Operations
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.

Encision Management Team Effectiveness

The company has return on total asset (ROA) of (0.0831) % which means that it has lost $0.0831 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2203) %, meaning that it created substantial loss on money invested by shareholders. Encision's management efficiency ratios could be used to measure how well Encision manages its routine affairs as well as how well it operates its assets and liabilities.

Encision Workforce Comparison

Encision is rated # 2 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 359. Encision holds roughly 31.0 in number of employees claiming about 9% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.09) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.09) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.09.

Encision Notable Stakeholders

An Encision stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Encision often face trade-offs trying to please all of them. Encision's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Encision's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Gregory TrudelCEO and President and DirectorProfile
Peter GearyVice President - OperationsProfile
Robert FriesIndependent DirectorProfile
David NewtonCo-Founder, VP of Technology and DirectorProfile
Vern KornelsenIndependent DirectorProfile
Mala RayController, Treasurer and Corporate SecretaryProfile
Brian JackmanVP MarketingProfile

About Encision Management Performance

The success or failure of an entity such as Encision often depends on how effective the management is. Encision management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Encision management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Encision management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado. Encision operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 31 people.
Please note, the presentation of Encision's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Encision's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Encision's management manipulating its earnings.

Encision Workforce Analysis

Traditionally, organizations such as Encision use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Encision within its industry.

Encision Manpower Efficiency

Return on Encision Manpower

Revenue Per Employee243.2K
Revenue Per Executive1.1M
Net Income Per Employee18.9K
Net Income Per Executive83.5K
Working Capital Per Employee45.8K
Working Capital Per Executive203K
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Consideration for investing in Encision Pink Sheet

If you are still planning to invest in Encision check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Encision's history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing